SUDA Pharmaceuticals Ltd. has entered into success-based agreements with two international specialty consulting groups as part of its strategic expansion of its business development footprint in the USA, Europe, Russia and China. Andrew Curtis has engaged an Illinois-based, boutique life sciences commercial services company. The company has been engaged to focus on the mid-tier US biotech and specialty pharmaceutical companies. The company's principal has over 30 years' experience working in leadership, commercial strategy development and tactical oversight with a large number of International and US-based pharmaceutical companies. JEZANS, a Hong Kong based commercial services company serving the life science industry in China, Europe and Russia, will focus on mid-sized private and State-owned companies in the above territories.